Category: COVID-19 Pathogenesis
Poster Session: COVID-19 Pathogenesis
Brenda Gomez-Gomez
Staff physician
The American British Cowdray Medical Center
Álvaro Obregón, Distrito Federal, Mexico
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Luis Espinosa-Aguilar
Staff physician
The American British Cowdray Medical Center
Mexico city, Distrito Federal, Mexico
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Javier Garcia-Guerrero
Staff physician
The American British Cowdray Medical Center
Mexico city, Distrito Federal, Mexico
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Irma Hoyo-Ulloa
Staff physician
The American British Cowdray Medical Center
Mexico city, Distrito Federal, Mexico
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Raquel Mendoza-Aguilar
Staff physician
The American British Cowdray Medical Center
Mexico City, Distrito Federal, Mexico
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Francisco Moreno-Sanchez
Internal Medicine Director
The American British Cowdray Medical Center
Mexico City, Distrito Federal, Mexico
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Benjamin Valente Acosta
Dr
Infectious diseases
Ciudad de Mexico, Distrito Federal, Mexico
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Diego Ontañon-Zurita
Staff physician
The American British Cowdray Medical Center
Mexico City, Distrito Federal, Mexico
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Over the past few years, it has been shown that T cells play an essential role in antiviral immunity, in the course of the COVID-19 pandemic some studies reported an association between lymphocytopenia and exhaustion of the surviving remaining T cells which are apparently functional in patients with acute COVID-19, specially in those with severe forms of presentation. Some studies have reported an association where less than 800 CD4 + T cells are negatively related to the survival of seriously ill patients with COVID -19.
Methods:
We included 19 patients admitted to our hospital (ABC Medical Center) from May 7 to 15, 2020 with a confirmed diagnosis of COVID-19 and were randomized into 2 groups according to the severity of the presentation (severe or critical) A determination of CD4 + T cells was made at admission, we also reported the need for invasive mechanical ventilation at some point of the hospitalization for each group, all patients were followed until their hospital discharge. One patient was excluded because he was still admitted at the time of the analysis.
Results:
Of the 18 patients included, 9 (50%) fulfilled criteria of severe and 9 (50%) of critical. The mean of CD4 + T cell was 455 (256-697) for the severe and 285.44 (145-430) for the critical (CI 95% P 0.46), the determination of CD8+ T cell was 212 (88-392) for the severe and 201 (59-534) for the critical (CI 95% P 1.19), of the critical patients 8 (88.9%) required invasive mechanical ventilation and only one non-invasive mechanical ventilation, while the severe patients only required support with supplemental oxygen by nasal cannula (9 (100%)).The mean lenght of hospitalization was 12.73 days (3-34) and all the patients survived until they were discharged home.
Conclusion:
As it has been reported in some studies, the pathogenesis of SARS-CoV-2 infection in humans is associated with a reduction and functional exhaustion of T cells in patients with COVID-19.In this study we presume that lower levels of CD4+T cells can be associated with critical forms of COVID 19 as the majority of critical patients in our report had < 300 CD4 +T cell count, while we need further studies with a greater number of patients and follow-up to establish reliable determinations, we propose than the levels of CD4+T cell count could be use as a good predictor of severity in COVID-19
